Cancer Immunotherapy Team

Our Cancer Immunotherapy Experts

Immunotherapy Institute Leadership

David E. Avigan, MD

Cancer Center Director, BIDMC; Senior Vice President of Cancer Services; BILH Chief, Division of Hematology and Hematologic Malignancies; Professor of Medicine, Harvard Medical School; Hematology; Medical Oncology

David F. McDermott, MD

Co-Director, Immunotherapy Institute & Kidney Tumor Program; Director, Biologic Therapy Program 

Jacalyn Rosenblatt, MD

Associate Chief, Division of Hematology and Hematologic Malignancies; Associate Professor of Medicine, Harvard Medical School; Hematology